Join
Live feed
·
INSIDERFilingvia Quantisnow
NewAmsterdam Pharma Company N.V. logo

Chief Executive Officer Davidson Michael H. sold 11,582 units of Ordinary Shares and was granted 81,000 units of Ordinary Shares, increasing direct ownership by 18% to 459,859 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NAMS· NewAmsterdam Pharma Company N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAMS (NewAmsterdam Pharma Company N.V.) and more on Quantisnow.

Chief Executive Officer Davidson Michael H. sold 11,582 units of Ordinary Shares and was granted 81,000 units of Ordinary Shares, increasing direct ownership by 18% to 459,859 units (SEC Form 4) | Quantisnow